Towards personalized medicine - the role of methotrexate
- PMID: 21441677
- PMCID: PMC3103148
Towards personalized medicine - the role of methotrexate
Comment on
-
Profiling single nucleotide polymorphisms (SNPs) across intracellular folate metabolic pathway in healthy Indians.Indian J Med Res. 2011 Mar;133(3):274-9. Indian J Med Res. 2011. PMID: 21441680 Free PMC article.
References
-
- Farber S, Diamond LK, Mercer RD, Sylvesterw RF, Jr, Wolff IA. Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid (aminopterin) N Engl J Med. 1948;238:787–93. - PubMed
-
- Gubner R, August S, Ginsberg V. Therapeutic suppression of tissue reactivity. II. Effect of aminopterin in rheumatoid arthritis and psoriasis. Am J Med Sci. 1951;221:176–82. - PubMed
-
- Kremer JM, Lee JK. The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis. Arthritis Rheum. 1986;29:822–31. - PubMed
-
- Alarcon GS, Tracy IC, Blackburn WD., Jr Methotrexate in rheumatoid arthritis. Toxic effects as the major factor in limiting long-term treatment. Arthritis Rheum. 1989;32:671–6. - PubMed
-
- Bathon JM, Martin RW, Fleischmann RM, Tesser JR, Schiff MH, Keystone EC, et al. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med. 2000;343:1586–93. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources